Skip to content
The Policy VaultThe Policy Vault

Pomalyst (pomalidomide) — Medica

Multiple myeloma

Initial criteria

  • Patient is ≥ 18 years of age
  • Patient has tried at least one other regimen

Approval duration

1 year